Johan Grunewald Selected Research

Sarcoidosis (Schaumann Disease)

1/2022	Reproductive and hormonal risk factors for sarcoidosis: a nested case-control study.
1/2022	Pulmonary and blood dendritic cells from sarcoidosis patients more potently induce IFNγ-producing Th1 cells compared with monocytes.
1/2022	Phenotypic and HLA-DRB1 allele characterization of Swedish cardiac sarcoidosis patients.
1/2022	Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.
11/2021	Risk of acute myocardial infarction in sarcoidosis: A population-based cohort study from Sweden.
10/2021	CD4+ T cells in the lungs of acute sarcoidosis patients recognize an Aspergillus nidulans epitope.
10/2021	HLA-DRB1 alleles associate with hypercalcemia in sarcoidosis.
4/2021	Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids.
1/2021	Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective 'target trial' emulated with Swedish real-world data.
1/2021	Monocytes in sarcoidosis are potent tumour necrosis factor producers and predict disease outcome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johan Grunewald Research Topics

Disease

63	Sarcoidosis (Schaumann Disease) 01/2022 - 09/2002
18	Inflammation (Inflammations) 01/2021 - 09/2002
8	Pulmonary Sarcoidosis 12/2018 - 11/2010
8	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 12/2009
7	Granuloma 01/2022 - 12/2008
7	Asthma (Bronchial Asthma) 01/2020 - 11/2007
6	Rheumatoid Arthritis 01/2020 - 01/2006
4	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 01/2007
4	Necrosis 01/2021 - 12/2007
4	Lung Diseases (Lung Disease) 07/2018 - 11/2007
2	Ventricular Tachycardia 01/2022 - 01/2021
2	Arthritis (Polyarthritis) 01/2022 - 09/2004
2	Infections 01/2021 - 01/2020
2	Fatigue 01/2020 - 01/2018
2	Fibrosis (Cirrhosis) 01/2019 - 03/2015
2	Pneumonia (Pneumonitis) 07/2018 - 12/2014
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Atrioventricular Block 01/2022
1	Hypercalcemia (Milk Alkali Syndrome) 10/2021
1	Type 2 Diabetes Mellitus (MODY) 04/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Antisynthetase syndrome 01/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Tertiary Lymphoid Structures 01/2018
1	Sleepiness 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Airway Obstruction (Choking) 01/2018
1	Disease Progression 01/2018

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2004
16	AntigensIBA 01/2022 - 09/2002
12	CytokinesIBA 01/2021 - 01/2006
9	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 11/2007
8	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 11/2006
7	AutoantigensIBA 01/2022 - 01/2006
7	Peptides (Polypeptides)IBA 01/2020 - 11/2007
7	Messenger RNA (mRNA)IBA 01/2018 - 09/2010
6	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 03/2004
5	Pharmaceutical PreparationsIBA 04/2021 - 08/2014
4	AntibodiesIBA 01/2020 - 01/2006
4	Immunoglobulin G (IgG)IBA 05/2019 - 03/2015
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2004
4	ProteomeIBA 01/2018 - 06/2013
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 01/2020
3	EpitopesIBA 10/2021 - 01/2006
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021 - 01/2020
3	Interleukin-2 (IL2)IBA 01/2020 - 07/2012
3	InterferonsIBA 01/2020 - 11/2010
3	VimentinIBA 01/2018 - 11/2007
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2010 - 01/2006
3	Nerve Growth Factor (NGF)IBA 11/2010 - 01/2006
3	Nerve Growth Factors (Neurotrophins)IBA 11/2010 - 01/2006
3	HLA-DR Antigens (HLA-DR)IBA 12/2009 - 01/2006
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2022 - 01/2020
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022 - 10/2021
2	AutoantibodiesIBA 01/2022 - 01/2020
2	AcidsIBA 12/2018 - 03/2017
2	LipidsIBA 12/2018 - 01/2012
2	EnzymesIBA 12/2018 - 08/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 12/2009
2	SmokeIBA 01/2018 - 12/2009
2	LigandsIBA 01/2016 - 01/2009
2	Interleukin-10 (Interleukin 10)IBA 01/2016 - 12/2009
2	ChemokinesIBA 01/2016 - 01/2006
2	Anti-Citrullinated Protein AntibodiesIBA 09/2015 - 01/2014
2	AllergensIBA 01/2014 - 01/2012
2	Peroxidase (Myeloperoxidase)IBA 07/2012 - 12/2008
2	CatalaseIBA 07/2012 - 12/2008
1	Estrogens (Estrogen)FDA Link 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	HLA-DRB1*04 antigenIBA 10/2021
1	CreatinineIBA 10/2021
1	Infliximab (Remicade)FDA Link 01/2021
1	Azathioprine (Imuran)FDA LinkGeneric 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	LeukotrienesIBA 01/2020
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 01/2020
1	montelukast (Singulair)FDA Link 01/2020
1	CD40 Ligand (CD40L)IBA 01/2020
1	EndocannabinoidsIBA 12/2018
1	Epoxide HydrolasesIBA 12/2018
1	SphingolipidsIBA 12/2018
1	EicosanoidsIBA 12/2018
1	Polysaccharides (Glycans)IBA 07/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	Granzymes (Granzyme)IBA 01/2018
1	MitogensIBA 01/2018
1	Immunoglobulin IsotypesIBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2018
1	CTLA-4 AntigenIBA 01/2018
1	PerforinIBA 01/2018
1	Interleukin-5 (Interleukin 5)IBA 01/2018
1	Vitamin D-Binding ProteinIBA 04/2017
1	leukotriene A4 hydrolaseIBA 04/2017

Therapy/Procedure

3	Therapeutics 01/2020 - 09/2015
2	Immunotherapy 03/2017 - 11/2006
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2022
1	Defibrillators (Defibrillator) 01/2021
1	Resistance Training 01/2020